Brain Glucose Metabolism in Cerebral Amyloid Angiopathy: An FDG-PET Study.

Background and Purpose: The in vivo diagnosis of cerebral amyloid angiopathy (CAA) is currently based on the Boston criteria, which largely rely on hemorrhagic features on brain magnetic resonance imaging. Adding to these criteria 18F-fluoro-deoxy-D-glucose (FDG) positron emission tomography, a wide...

Full description

Bibliographic Details

Published in:	Stroke (00392499) Vol. 52; no. 4; pp. 1478 - 1483
Main Authors:	Bergeret, Sébastien, Queneau, Mathieu, Rodallec, Mathieu, Landeau, Brigitte, Chetelat, Gaël, Hong, Young T., Dumurgier, Julien, Hugon, Jacques, Paquet, Claire, Farid, Karim, Baron, Jean-Claude
Format:	research Journal Article
Published:	Lippincott Williams & Wilkins Apr2021
Online Access:	View this record in EBSCOhost